meta-iodobenzylguanidine (123I mIBG)

meta-iodobenzylguanidine (123I mIBG) · GE Healthcare

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for meta-iodobenzylguanidine (123I mIBG), covering 2019-05-31 to 2019-05-31. Get the full timeline:

Most recent: Clinical Trial Update: Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma [Phase 3]

See pricing